SB 83Session 2025
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Votes
-
Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2
3 yes2 no
-
Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2
3 yes2 no
Legislative history
-
Senate
Failed to pass pursuant to Senate Joint Resolution 1
-
Senate
Available for scheduling
-
Senate
Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2
-
Senate
Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2
-
Senate
Executive action taken
-
Senate
Public hearing held
-
Senate
Senate Substitute Amendment 2 offered by Senator James
-
Senate
Representative Subeck added as a cosponsor
-
Senate
Senate Substitute Amendment 1 offered by Senator James
-
Senate
Fiscal estimate received
-
Senate
Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families
-
Senate
Introduced by Senators James, Cabral-Guevara and Wanggaard; cosponsored by Representatives Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen and Tittl